Cuiyan Yu - Search Results

Year	Number of Results
2008	3
2009	3
2010	1
2014	1
2015	6
2016	5
2017	1
2018	3
2019	4
2020	6
2021	5
2022	11
2023	15
2024	8

1

A ROS-Responsive Liposomal Composite Hydrogel Integrating Improved Mitochondrial Function and Pro-Angiogenesis for Efficient Treatment of Myocardial Infarction.

Zheng Z, Lei C, Liu H, Jiang M, Zhou Z, Zhao Y, Yu CY, Wei H. Zheng Z, et al. Adv Healthc Mater. 2022 Oct;11(19):e2200990. doi: 10.1002/adhm.202200990. Epub 2022 Jul 27. Adv Healthc Mater. 2022. PMID: 35848825

2

Promotion of ICD via Nanotechnology.

Qin Y, Zhang H, Li Y, Xie T, Yan S, Wang J, Qu J, Ouyang F, Lv S, Guo Z, Wei H, Yu CY. Qin Y, et al. Macromol Biosci. 2023 Sep;23(9):e2300093. doi: 10.1002/mabi.202300093. Epub 2023 May 7. Macromol Biosci. 2023. PMID: 37114599 Review.

3

Application of Cyclodextrin for Cancer Immunotherapy.

Wei X, Yu CY, Wei H. Wei X, et al. Molecules. 2023 Jul 24;28(14):5610. doi: 10.3390/molecules28145610. Molecules. 2023. PMID: 37513483 Free PMC article. Review.

4

Engineered cyclodextrin-based supramolecular hydrogels for biomedical applications.

Zhao Y, Zheng Z, Yu CY, Wei H. Zhao Y, et al. J Mater Chem B. 2023 Dec 22;12(1):39-63. doi: 10.1039/d3tb02101g. J Mater Chem B. 2023. PMID: 38078497 Review.

5

Immunomodulatory Peptides for Tumor Treatment.

Song Y, Lei L, Cai X, Wei H, Yu CY. Song Y, et al. Adv Healthc Mater. 2024 Apr 24:e2400512. doi: 10.1002/adhm.202400512. Online ahead of print. Adv Healthc Mater. 2024. PMID: 38657003 Review.

6

Multicyclic topology-enhanced anticancer drug delivery.

Ma W, Kang GY, Sun L, Meng C, Liu Y, Zheng Z, Jiang MC, Wang D, Pun SH, Yu CY, Wei H. Ma W, et al. J Control Release. 2022 May;345:278-291. doi: 10.1016/j.jconrel.2022.03.018. Epub 2022 Mar 17. J Control Release. 2022. PMID: 35306117

7

Peptide-functionalized delivery vehicles for enhanced cancer therapy.

Tang SY, Wei H, Yu CY. Tang SY, et al. Int J Pharm. 2021 Jan 25;593:120141. doi: 10.1016/j.ijpharm.2020.120141. Epub 2020 Dec 3. Int J Pharm. 2021. PMID: 33279713 Review.

8

Engineered Exosomes as Theranostic Platforms for Cancer Treatment.

Yang X, Xie X, Liu S, Ma W, Zheng Z, Wei H, Yu CY. Yang X, et al. ACS Biomater Sci Eng. 2023 Oct 9;9(10):5479-5503. doi: 10.1021/acsbiomaterials.3c00745. Epub 2023 Sep 11. ACS Biomater Sci Eng. 2023. PMID: 37695590 Review.

9

Recent advances in nanostructured substrates for surface-enhanced infrared absorption spectroscopy.

Wang J, Zeng P, Xiao X, Zhou C, Wei H, Yu C. Wang J, et al. Among authors: yu c. Nanotechnology. 2023 Jul 6;34(38). doi: 10.1088/1361-6528/acd943. Nanotechnology. 2023. PMID: 37236158 Review.

10

A Sodium Alginate-Based Multifunctional Nanoplatform for Synergistic Chemo-Immunotherapy of Hepatocellular Carcinoma.

Huang C, Xie T, Liu Y, Yan S, OuYang F, Zhang H, Lei L, He D, Wei H, Yu CY. Huang C, et al. Adv Mater. 2023 Aug;35(33):e2301352. doi: 10.1002/adma.202301352. Epub 2023 Jun 5. Adv Mater. 2023. PMID: 37216573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year